Helptext

Movies



Company Information

Company NameA1M Pharma AB
Company Idea

A1M Pharma AB bedriver utveckling och kommersialisering av i först hand behandling och diagnostik av havandeskapsförgiftning baserad på proteinet A1M, alfa-1-mikroglobulin samt fetalt hemoglobin som diagnostisk markör.

Phone070-918 38 50CEOTomas Eriksson
E-mailinfo(snabel-a)a1m(punkt)seChairm. of the BoardMartin Austin
Homepagehttp://www.a1m.se 

Instrument Information

Full NameA1M PharmaShort NameA1M
No of shares54,615,448Par Value0.04 SEK
TypeShareISIN codeSE0005876828

Price Information

+/-0.23
%22.55
Latest1.25
High1.37
Low1.20
Volume475,906
Turnover (SEK)594,463
Market Cap (MSEK)68.3

Orders

VolumeBidAskVolume
11,9871.241.251,856
24,6971.231.2628,505
9,5001.221.2711,000
11,0001.211.2813,400
30,1501.201.2911,904
15,0001.191.3021,000
50,5931.181.341,500
30,0001.171.3542,102
9,6551.161.3829,754
10,0001.121.391,694
301.101.4051,197
13,0001.081.437,000
10,0001.061.44108,500
1,1811.021.4515,600
20,0071.001.491,694
5,0000.991.5023,498
42,1050.951.511,000
12,6670.901.53400
25,0000.851.558,000
1,0000.841.656,999

Deals

TimeBuyerSellerPriceVolume
9:12 AMAVAAVA1.25100
9:12 AMAVAAVA1.2544
9:11 AMAVANRD1.246,413
9:11 AMAVANRD1.241,087
9:10 AMAVAAVA1.241,500
9:09 AMAVAAVA1.244,000
9:09 AMAVAAVA1.26753
9:08 AMAVAAVA1.243,300
9:07 AMAVAAVA1.24113
9:07 AMAVAAVA1.2425

Scheduled Reports

DateReport
2017-04-27Årsstämma
2017-05-24Delårsrapport ett
2017-08-25Halvårsrapport
2017-11-22Delårsrapport tre
2018-02-23Bokslutskommuniké för 2017




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se